Active surveillance for patients with Low-risk Prostate Cancer: How Does PSA Doubling time Affect the Risk of Histopathological Progression at Re-biopsy?

Frderik Birkebæk Thomsen; Martin Andreas Røder; Helle Hvarness; Peter Iversen; Klaus Brasso

doi:10.1016/S0090-4295(12)00879-5

Active surveillance for patients with Low-risk Prostate Cancer: How Does PSA Doubling time Affect the Risk of Histopathological Progression at Re-biopsy?

Frderik Birkebæk Thomsen, Martin Andreas Røder, Helle Hvarness, Peter Iversen, Klaus Brasso

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning

11 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Urology
Vol/bind	80
Udgave nummer	3
Sider (fra-til)	1-135
ISSN	0090-4295
DOI	https://doi.org/10.1016/S0090-4295(12)00879-5
Status	Udgivet - sep. 2012

Adgang til dokumentet

10.1016/S0090-4295(12)00879-5

Biblioteksadgang?

Tjek tilgængelighed hos det Kgl. Bibliotek

Citationsformater

@article{144928bbdf114e6691ca55132d3750b5,

title = "Active surveillance for patients with Low-risk Prostate Cancer: How Does PSA Doubling time Affect the Risk of Histopathological Progression at Re-biopsy?",

author = "Thomsen, {Frderik Birkeb{\ae}k} and R{\o}der, {Martin Andreas} and Helle Hvarness and Peter Iversen and Klaus Brasso",

year = "2012",

month = sep,

doi = "10.1016/S0090-4295(12)00879-5",

language = "English",

volume = "80",

pages = "1--135",

journal = "Urology",

issn = "0090-4295",